MIT engineers develop nanoparticle method to reprogram immune cells for cancer treatment
Researchers use ligand-directed lipid nanoparticles to engineer CAR natural killer cells in vivo, targeting autoimmune disorders and lymphoma.
The story so far
2 publishers have covered this in 2 articles since 13 Oct 2026. Nature Biotechnology published first, on 13 October at 00:00 UTC; Phys.org - latest science and technology news stories followed 16h 20m later. The most recent article, from Phys.org - latest science and technology news stories, appeared on 13 October at 16:20 UTC.
Outlets reporting it: Nature Biotechnology (major outlet), Phys.org - latest science and technology news stories.
No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.
Sources
Every article we clustered into this story. Headlines link to the publisher.
In this story
- MIT